These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2633393)
21. [Radioimmunoassay of E antigen and anti-E antibody system of hepatitis B virus]. Novak I; Kselikova M; Urbankova I Probl Gematol Pereliv Krovi; 1982 Mar; 27(3):55-7. PubMed ID: 7088919 [No Abstract] [Full Text] [Related]
22. [Investigation on human carriage of HBsAg in Qingtian County]. Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Apr; 4(2):79-82. PubMed ID: 6883488 [No Abstract] [Full Text] [Related]
23. [Interferon treatment in chronic hepatitis B]. Pastore G; Santantonio T; Milella M; Iacovazzi T; Longo A; Pietromatera G Minerva Gastroenterol Dietol; 1995 Mar; 41(1):97-102. PubMed ID: 7619970 [No Abstract] [Full Text] [Related]
24. [Treatment of chronic hepatitis B and C with alpha interferon]. Hess G Z Gastroenterol Verh; 1991 Mar; 26():149-51. PubMed ID: 1714130 [No Abstract] [Full Text] [Related]
25. Treatment of children with chronic hepatitis B with a combination of steroids and human lymphoblastoid interferon. Giacchino R; Facco F; Giambartolomei G; Navone C; Timitilli A; Cirillo C; Barigione G; Terragna A Chemioterapia; 1988 Dec; 7 Suppl 3():20-5. PubMed ID: 3073870 [TBL] [Abstract][Full Text] [Related]
26. Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B. Alberti A; Fattovich G; Pontisso P; Brollo L; Belussi F; Ruol A Chemioterapia; 1988 Dec; 7 Suppl 3():15-9. PubMed ID: 3073869 [TBL] [Abstract][Full Text] [Related]
27. [Hepatitis B: serological strategy and epidemiological aspects]. Penna R; Rabagliati AM G Batteriol Virol Immunol; 1981; 74(1-6):145-62. PubMed ID: 7030851 [No Abstract] [Full Text] [Related]
28. Immunoglobulin M antibody to hepatitis B core antigen (IgM anti-HBc) as a marker of interferon therapy in patients with persistent hepatitis B virus infection. Nakajima E; Tsuji T; Kachi K; Kagawa K; Okanoue T; Takino T; Yamada A; Imanishi J Biken J; 1987 Mar; 30(1):17-23. PubMed ID: 3675547 [TBL] [Abstract][Full Text] [Related]
29. [The behavior of the HBeAg-anti-HBe system in chronic hepatitis]. Musca A; Cordova C; Barnaba V; Bonavita MS; Zaccari C; Levrero M Minerva Dietol Gastroenterol; 1983; 29(1):19-26. PubMed ID: 6843853 [No Abstract] [Full Text] [Related]
30. Simultaneously acute hepatitis B virus and C virus coinfection and subsequent chronic hepatitis C. Chen SW; Lee TS; Hu CC; Chang LC; Chien RN Scand J Infect Dis; 2007; 39(4):351-4. PubMed ID: 17454901 [TBL] [Abstract][Full Text] [Related]
31. [Serologic indicators in infection by hepatitis virus type B]. Hernández N; Rodríguez JR; Gorbea HF; Colón Quintana M; Christenson B; Ramírez-Ronda CH Bol Asoc Med P R; 1984 Jun; 76(6):245-8. PubMed ID: 6590058 [No Abstract] [Full Text] [Related]
32. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial. Mazzella G; Villanova N; Abdu-Ahmed M; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E Chemioterapia; 1988 Dec; 7 Suppl 3():12-4. PubMed ID: 3073868 [TBL] [Abstract][Full Text] [Related]
33. [Circulation of the markers of the hepatitis B virus in different clinical forms of the disease]. Frolov AF; Raksha EA; Nagornova TF; Vasilenko LG Vrach Delo; 1984 Apr; (4):108-11. PubMed ID: 6741040 [No Abstract] [Full Text] [Related]
34. [Hepatitis B in childhood]. Calzia R; Marazzi MG; Bonura ML; Giovale M; Massacane R; Piscopo R; Santoni O; Zauli C; Navone C; Ciravegna B Minerva Pediatr; 1984 Jun; 36(12):605-9. PubMed ID: 6513895 [No Abstract] [Full Text] [Related]
35. Alpha 2 recombinant interferon in the treatment of chronic hepatitis delta virus (HDV) hepatitis. Rosina F; Saracco G; Lattore V; Quartarone V; Rizzetto M; Verme G; Trinchero P; Sansalvadore F; Smedile A Prog Clin Biol Res; 1987; 234():299-303. PubMed ID: 3628384 [No Abstract] [Full Text] [Related]
36. [Comparative study of the "e" system (HBeAG/anti-HBeAg) and core antibodies in aggressive chronic hepatitis and liver cirrhosis]. Marinucci G; Muglia M; Di Giacomo C; Petrucci L; Mancini R; Costa F; Bachetoni A Quad Sclavo Diagn; 1981 Mar; 17(1):81-5. PubMed ID: 7313073 [No Abstract] [Full Text] [Related]
37. [Favorable outcome in chronic active hepatitis caused by B virus in childhood]. Cadrobbi P; Bortolotti F; Crivellaro C; Rugge M; Armigliato M; Realdi G; Bertaggia A Minerva Pediatr; 1984 Jul; 36(13-14):685-9. PubMed ID: 6503897 [No Abstract] [Full Text] [Related]
38. Hepatitis B viral infection: part I. Clinical features. Dzik WH; Alter HJ Am Fam Physician; 1982 Aug; 26(2):119-26. PubMed ID: 6285684 [TBL] [Abstract][Full Text] [Related]
39. [Distribution of serologic markers of hepatitis B in a sample of the population of Cremona province]. Romanini G; Bodini U; Pennacchio A; Cavalli P; Carpanelli R; Pecoroni L; Sampaoli G; Bini MG; D'Avossa A; Frosi A Riv Emoter Immunoematol; 1984; 31(2):165-73. PubMed ID: 6536097 [No Abstract] [Full Text] [Related]
40. Interferon in chronic active hepatitis B. Preliminary results. Waked I; Amin M; Abd-el Fattah SA; Osman L; Sabbour M Chemioterapia; 1988 Jun; 7(3):198-202. PubMed ID: 3168077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]